Suppression of Hepcidin Expression and Iron Overload Mediate Salmonella Susceptibility in Ankyrin 1 ENU-Induced Mutant

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Yuki, Kyoko E ^a   Eva, Megan M ^a   Richer, Etienne ^a   Chung, Dudley ^c   Paquet, Marilène ^b   Cellier, Mathieu ^d   Canonne Hergaux, François ^e,g,h   Vaulont, Sophie ^f   Vidal, Silvia M ^a   Malo, Danielle ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

^e University of Toulouse III   (France)

^f INSTITUT COCHIN   (France)

^g CNRS   (France)

^h UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANKYRIN; ANKYRIN 1; ASPARTATE AMINOTRANSFERASE; ERYTHROPOIETIN; ETHYLNITROSOUREA; GROWTH DIFFERENTIATION FACTOR 15; HEME OXYGENASE 1; HEPCIDIN; IRON; NITROGEN; UNCLASSIFIED DRUG; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKYRIN 1 GENE; ARTICLE; BACTERIAL LOAD; CHEMICAL MUTAGENESIS; CHROMOSOME 8; CONTROLLED STUDY; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; GENE; GENE LOCUS; GENETIC IDENTIFICATION; HEART WEIGHT; HEMOLYTIC ANEMIA; HETEROZYGOTE; HOST RESISTANCE; HYPERBILIRUBINEMIA; INFECTION SENSITIVITY; IRON OVERLOAD; JAUNDICE; KIDNEY MASS; MALE; MOUSE; MUTANT; NONHUMAN; NONSENSE MUTATION; PROTEIN EXPRESSION; SALMONELLA TYPHIMURIUM; SALMONELLOSIS; SPLENOMEGALY; SURVIVAL; TISSUE DISTRIBUTION; UREA NITROGEN BLOOD LEVEL; WILD TYPE;

ANEMIA, HEMOLYTIC; ANIMALS; ANKYRINS; ANTIMICROBIAL CATIONIC PEPTIDES; CODON, NONSENSE; ERYTHROCYTES; ERYTHROPOIETIN; ETHYLNITROSOUREA; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GROWTH DIFFERENTIATION FACTOR 15; HEME OXYGENASE-1; HETEROZYGOTE; HOMOZYGOTE; IRON; IRON OVERLOAD; LIVER; MEMBRANE PROTEINS; MICE; SALMONELLA INFECTIONS; SALMONELLA TYPHIMURIUM; SURVIVAL ANALYSIS;

EID: 84873500007     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055331     Document Type: Article

References (57)

1. Mastroeni P, Maskell D (2006) Salmonella infections: clinical, immunological, and molecular aspects. Cambridge, UK; New York: Cambridge University Press.
2. Casanova JL, Fieschi C, Zhang SY, Abel L, (2008) Revisiting human primary immunodeficiencies. J Intern Med 264: 115-127.
3. Gordon MA, (2008) Salmonella infections in immunocompromised adults. J Infect 56: 413-422.
4. Bustamante J, Zhang SY, von Bernuth H, Abel L, Casanova JL (2008) From infectious diseases to primary immunodeficiencies. Immunol Allergy Clin North Am 28: 235-258, vii.
5. Schaible UE, Kaufmann SH, (2004) Iron and microbial infection. Nat Rev Microbiol 2: 946-953.
6. Vento S, Cainelli F, Cesario F, (2006) Infections and thalassaemia. Lancet Infect Dis 6: 226-233.
7. Vidal S, Gros P, Skamene E, (1995) Natural resistance to infection with intracellular parasites: molecular genetics identifies Nramp1 as the Bcg/Ity/Lsh locus. J Leukoc Biol 58: 382-390.
8. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, et al. (1999) Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J Exp Med 189: 615-625.
9. Roy MF, Riendeau N, Bedard C, Helie P, Min-Oo G, et al. (2007) Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice. J Exp Med 204: 2949-2961.
10. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
11. Rubtsov AM, Lopina OD, (2000) Ankyrins. FEBS Lett 482: 1-5.
12. Perrotta S, Gallagher PG, Mohandas N, (2008) Hereditary spherocytosis. Lancet 372: 1411-1426.
13. Birkenmeier CS, Gifford EJ, Barker JE, (2003) Normoblastosis, a murine model for ankyrin-deficient hemolytic anemia, is caused by a hypomorphic mutation in the erythroid ankyrin gene Ank1. Hematol J 4: 445-449.
14. Rank G, Sutton R, Marshall V, Lundie RJ, Caddy J, et al. (2009) Novel roles for erythroid Ankyrin-1 revealed through an ENU-induced null mouse mutant. Blood 113: 3352-3362.
15. Hughes MR, Anderson N, Maltby S, Wong J, Berberovic Z, et al. (2011) A novel ENU-generated truncation mutation lacking the spectrin-binding and C-terminal regulatory domains of Ank1 models severe hemolytic hereditary spherocytosis. Exp Hematol 39: 305-320 e302.
16. Harris BS, Ward-Bailey PF, Johnson KR, Bronson RT, Reinholdt LG, et al. (2009) A new pale lethal mouse mutation (pale) has been identified on Chromosome 8. MGI Direct Data Submission.
17. Greth A, Lampkin S, Mayura-Guru P, Rodda F, Drysdale K, et al. (2012) A novel ENU-mutation in ankyrin-1 disrupts malaria parasite maturation in red blood cells of mice. PLoS One 7: e38999.
18. Gallagher PG, (2005) Hematologically important mutations: ankyrin variants in hereditary spherocytosis. Blood Cells Mol Dis 35: 345-347.
19. Eber SW, Gonzalez JM, Lux ML, Scarpa AL, Tse WT, et al. (1996) Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nat Genet 13: 214-218.
20. Delaunay J, (2002) Molecular basis of red cell membrane disorders. Acta Haematol 108: 210-218.
21. Lesbordes-Brion JC, Viatte L, Bennoun M, Lou DQ, Ramey G, et al. (2006) Targeted disruption of the hepcidin 1 gene results in severe hemochromatosis. Blood 108: 1402-1405.
22. Richer E, Prendergast C, Zhang DE, Qureshi ST, Vidal SM, et al. (2010) N-ethyl-N-nitrosourea-induced mutation in ubiquitin-specific peptidase 18 causes hyperactivation of IFN-alphass signaling and suppresses STAT4-induced IFN-gamma production, resulting in increased susceptibility to Salmonella typhimurium. J Immunol 185: 3593-3601.
23. Boyer E, Bergevin I, Malo D, Gros P, Cellier MF, (2002) Acquisition of Mn(II) in addition to Fe(II) is required for full virulence of Salmonella enterica serovar Typhimurium. Infect Immun 70: 6032-6042.
24. Team RDC (2011) R: A language and environment for statistical computing. Vienna, Austria.
25. Bennett V, Healy J, (2008) Organizing the fluid membrane bilayer: diseases linked to spectrin and ankyrin. Trends Mol Med 14: 28-36.
26. Peters LL, Lux SE, (1993) Ankyrins: structure and function in normal cells and hereditary spherocytes. Semin Hematol 30: 85-118.
27. Bennett V, (1992) Ankyrins. Adaptors between diverse plasma membrane proteins and the cytoplasm. J Biol Chem 267: 8703-8706.
28. Veuthey T, D'Anna MC, Roque ME, (2008) Role of the kidney in iron homeostasis: renal expression of Prohepcidin, Ferroportin, and DMT1 in anemic mice. Am J Physiol Renal Physiol 295: F1213-1221.
29. Kulaksiz H, Theilig F, Bachmann S, Gehrke SG, Rost D, et al. (2005) The iron-regulatory peptide hormone hepcidin: expression and cellular localization in the mammalian kidney. J Endocrinol 184: 361-370.
30. Smith CP, Thevenod F, (2009) Iron transport and the kidney. Biochim Biophys Acta 1790: 724-730.
31. Sanchez-Lopez JY, Camacho AL, Magana MT, Ibarra B, Perea FJ, (2003) Red cell membrane protein deficiencies in Mexican patients with hereditary spherocytosis. Blood Cells Mol Dis 31: 357-359.
32. Boguslawska DM, Heger E, Chorzalska A, Nierzwicka M, Holojda J, et al. (2004) Hereditary spherocytosis: identification of several HS families with ankyrin and band 3 deficiency in a population of southwestern Poland. Ann Hematol 83: 28-33.
33. Gardenghi S, Grady RW, Rivella S, (2010) Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in beta-thalassemia. Hematol Oncol Clin North Am 24: 1089-1107.
34. Jones RL, Peterson CM, Grady RW, Kumbaraci T, Cerami A, et al. (1977) Effects of iron chelators and iron overload on Salmonella infection. Nature 267: 63-65.
35. Walker EM Jr, Walker SM, (2000) Effects of iron overload on the immune system. Ann Clin Lab Sci 30: 354-365.
36. Collins HL, Kaufmann SH, Schaible UE, (2002) Iron chelation via deferoxamine exacerbates experimental salmonellosis via inhibition of the nicotinamide adenine dinucleotide phosphate oxidase-dependent respiratory burst. J Immunol 168: 3458-3463.
37. Kovtunovych G, Eckhaus MA, Ghosh MC, Ollivierre-Wilson H, Rouault TA, (2010) Dysfunction of the heme recycling system in heme oxygenase 1-deficient mice: effects on macrophage viability and tissue iron distribution. Blood 116: 6054-6062.
38. Nix RN, Altschuler SE, Henson PM, Detweiler CS, (2007) Hemophagocytic macrophages harbor Salmonella enterica during persistent infection. PLoS Pathog 3: e193.
39. Cunnington AJ, de Souza JB, Walther M, Riley EM, (2012) Malaria impairs resistance to Salmonella through heme- and heme oxygenase-dependent dysfunctional granulocyte mobilization. Nat Med 18: 120-127.
40. Wareing M, Ferguson CJ, Green R, Riccardi D, Smith CP, (2000) In vivo characterization of renal iron transport in the anaesthetized rat. J Physiol 524 Pt 2: 581-586.
41. Zhou XJ, Laszik Z, Wang XQ, Silva FG, Vaziri ND, (2000) Association of renal injury with increased oxygen free radical activity and altered nitric oxide metabolism in chronic experimental hemosiderosis. Lab Invest 80: 1905-1914.
42. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, et al. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306: 2090-2093.
43. Hentze MW, Muckenthaler MU, Galy B, Camaschella C, (2010) Two to tango: regulation of Mammalian iron metabolism. Cell 142: 24-38.
44. Ganz T, (2011) Hepcidin and iron regulation, 10 years later. Blood 117: 4425-4433.
45. Tanno T, Bhanu NV, Oneal PA, Goh SH, Staker P, et al. (2007) High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 13: 1096-1101.
46. Tanno T, Noel P, Miller JL, (2010) Growth differentiation factor 15 in erythroid health and disease. Curr Opin Hematol 17: 184-190.
47. Kattamis A, Papassotiriou I, Palaiologou D, Apostolakou F, Galani A, et al. (2006) The effects of erythropoetic activity and iron burden on hepcidin expression in patients with thalassemia major. Haematologica 91: 809-812.
48. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, et al. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 94: 11514-11519.
49. Lakhal S, Talbot NP, Crosby A, Stoepker C, Townsend AR, et al. (2009) Regulation of growth differentiation factor 15 expression by intracellular iron. Blood 113: 1555-1563.
50. Nairz M, Theurl I, Schroll A, Theurl M, Fritsche G, et al. (2009) Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114: 3642-3651.
51. Ferguson CJ, Wareing M, Ward DT, Green R, Smith CP, et al. (2001) Cellular localization of divalent metal transporter DMT-1 in rat kidney. Am J Physiol Renal Physiol 280: F803-814.
52. Gordeuk VR, Miasnikova GY, Sergueeva AI, Niu X, Nouraie M, et al. (2011) Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression. Blood 118: 5278-5282.
53. Viatte L, Nicolas G, Lou DQ, Bennoun M, Lesbordes-Brion JC, et al. (2006) Chronic hepcidin induction causes hyposideremia and alters the pattern of cellular iron accumulation in hemochromatotic mice. Blood 107: 2952-2958.
54. Gardenghi S, Ramos P, Marongiu MF, Melchiori L, Breda L, et al. (2010) Hepcidin as a therapeutic tool to limit iron overload and improve anemia in beta-thalassemic mice. J Clin Invest 120: 4466-4477.
55. Ramos E, Ruchala P, Goodnough JB, Kautz L, Preza GC, et al. (2012) Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood 120: 3829-3836.
56. Sow FB, Florence WC, Satoskar AR, Schlesinger LS, Zwilling BS, et al. (2007) Expression and localization of hepcidin in macrophages: a role in host defense against tuberculosis. J Leukoc Biol 82: 934-945.
57. Lux SE, John KM, Bennett V, (1990) Analysis of cDNA for human erythrocyte ankyrin indicates a repeated structure with homology to tissue-differentiation and cell-cycle control proteins. Nature 344: 36-42.